Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMAC-SF | Vemurafenib | JNK-IN-8 | 3.160 | 1.000 | uM | 72 | hr | 2 | 462 | 141 | 0.3152 | 0.3656 | 0.3052 | 0.2907 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 3.160 | 1.000 | uM | 72 | hr | 3 | 309 | 93 | 0.2121 | 0.3656 | 0.3010 | 0.2907 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 3.160 | 3.160 | uM | 72 | hr | 1 | 348 | 58 | 0.2848 | 0.2478 | 0.1667 | 0.2217 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 3.160 | 3.160 | uM | 72 | hr | 2 | 338 | 89 | 0.2445 | 0.2478 | 0.2633 | 0.2217 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 3.160 | 3.160 | uM | 72 | hr | 3 | 285 | 67 | 0.2141 | 0.2478 | 0.2351 | 0.2217 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 1 | 1026 | 46 | 0.9922 | 1.0000 | 0.0448 | 0.0473 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 2 | 1114 | 46 | 1.0813 | 1.0000 | 0.0413 | 0.0473 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 3 | 969 | 54 | 0.9264 | 1.0000 | 0.0557 | 0.0473 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 1 | 1207 | 52 | 1.1694 | 1.2926 | 0.0431 | 0.0509 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 2 | 1398 | 83 | 1.3314 | 1.2926 | 0.0594 | 0.0509 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 3 | 1432 | 72 | 1.3770 | 1.2926 | 0.0503 | 0.0509 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 1.000 | uM | 72 | hr | 1 | 811 | 41 | 0.7796 | 0.6166 | 0.0506 | 0.0527 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 1.000 | uM | 72 | hr | 2 | 555 | 40 | 0.5214 | 0.6166 | 0.0721 | 0.0527 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 1.000 | uM | 72 | hr | 3 | 562 | 20 | 0.5488 | 0.6166 | 0.0356 | 0.0527 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 1 | 792 | 31 | 0.7705 | 0.6021 | 0.0391 | 0.0426 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 2 | 619 | 26 | 0.6004 | 0.6021 | 0.0420 | 0.0426 |
MMAC-SF | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 3 | 451 | 21 | 0.4354 | 0.6021 | 0.0466 | 0.0426 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 1 | 736 | 41 | 0.7037 | 0.8032 | 0.0557 | 0.0480 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 2 | 894 | 41 | 0.8637 | 0.8032 | 0.0459 | 0.0480 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.000 | uM | 72 | hr | 3 | 869 | 37 | 0.8424 | 0.8032 | 0.0426 | 0.0480 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 1 | 790 | 54 | 0.7452 | 0.9150 | 0.0684 | 0.0572 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 2 | 971 | 59 | 0.9234 | 0.9150 | 0.0608 | 0.0572 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 0.316 | uM | 72 | hr | 3 | 1110 | 47 | 1.0763 | 0.9150 | 0.0423 | 0.0572 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 1.000 | uM | 72 | hr | 1 | 718 | 55 | 0.6713 | 0.5724 | 0.0766 | 0.0768 |
MMAC-SF | Vemurafenib | PF562271 | 0.100 | 1.000 | uM | 72 | hr | 2 | 618 | 52 | 0.5731 | 0.5724 | 0.0841 | 0.0768 |